Evercore ISI Group Maintains Outperform on BioNTech, Lowers Price Target to $110

Benzinga · 3d ago
Evercore ISI Group analyst Cory Kasimov maintains BioNTech (NASDAQ:BNTX) with a Outperform and lowers the price target from $120 to $110.